Mephenytoin

CHEMBL861 Phase 4 معتمد Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
218.2 g/mol
LogP
1.5
Phase
4

An anticonvulsant related to phenytoin used to control certain types of seizures in patients who have not responded to safer first-line antiepileptic drugs. It carries a higher risk of serious side effects compared to other seizure medications and is rarely used today.

الوزن الجزيئي

218,2500 g/mol

LogP

1,50

TPSA

49,40 Ų

قاعدة ليبينسكي للخمسة

ناجح

آلية العمل

Modulates neuronal excitability through one or more mechanisms including blockade of voltage-gated sodium channels, enhancement of GABAergic inhibition, or modulation of calcium channels. This reduces the frequency and severity of seizure activity.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

الآلية

Modulates neuronal excitability through one or more mechanisms including blockade of voltage-gated sodium channels, enhancement of GABAergic inhibition, or modulation of calcium channels. This reduces the frequency and severity of …

البنية ثنائية الأبعاد

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCC1(c2ccccc2)NC(=O)N(C)C1=O

InChI

InChI=1S/C12H14N2O2/c1-3-12(9-7-5-4-6-8-9)10(15)14(2)11(16)13-12/h4-8H,3H2,1-2H3,(H,13,16)

Molecular Formula

C12H14N2O2

HBD / HBA

1 / 2

الروابط القابلة للدوران

2

الذرات الثقيلة

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

An anticonvulsant related to phenytoin used to control certain types of seizures in patients who have not responded to safer first-line antiepileptic drugs. It carries a higher risk of serious side effects compared to other seizure medications and is rarely used today.

Modulates neuronal excitability through one or more mechanisms including blockade of voltage-gated sodium channels, enhancement of GABAergic inhibition, or modulation of calcium channels. This reduces the frequency and severity of seizure activity.

Yes, Mephenytoin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL861. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 4060. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.